Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

A primer on medicinal cannabis safety and potential adverse effects
Jonathon C. Arnold
Australian Journal of General Practice (2021) Vol. 50, Iss. 6, pp. 345-350
Open Access | Times Cited: 32

Showing 1-25 of 32 citing articles:

The safety and efficacy of low oral doses of cannabidiol: An evaluation of the evidence
Jonathon C. Arnold, Danielle McCartney, Anastasia Suraev, et al.
Clinical and Translational Science (2022) Vol. 16, Iss. 1, pp. 10-30
Open Access | Times Cited: 54
Cannabinoids, Insomnia, and Other Sleep Disorders
Isobel Lavender, Iain S. McGregor, Anastasia Suraev, et al.
CHEST Journal (2022) Vol. 162, Iss. 2, pp. 452-465
Closed Access | Times Cited: 29
Adulteration of low‐delta‐9‐tetrahydrocannabinol products with synthetic cannabinoids: Results from drug checking services
Manuela Carla Monti, Jill Zeugin, Konrad R. Koch, et al.
Drug Testing and Analysis (2022) Vol. 14, Iss. 6, pp. 1026-1039
Open Access | Times Cited: 25
Medicinal cannabis in the treatment of chronic pain
Luke Henderson, Vicki Kotsirilos, Elizabeth A. Cairns, et al.
Australian Journal of General Practice (2021) Vol. 50, Iss. 10, pp. 724-732
Open Access | Times Cited: 32
Medicinal cannabis for the treatment of anxiety disorders
Maximus Berger, G. Paul Amminger, Iain S. McGregor
Australian Journal of General Practice (2022) Vol. 51, Iss. 8, pp. 586-592
Open Access | Times Cited: 19
The endocannabinoid system as a putative target for the development of novel drugs for the treatment of psychiatric illnesses
Matthew N. Hill, Margaret Haney, Cecilia J. Hillard, et al.
Psychological Medicine (2023) Vol. 53, Iss. 15, pp. 7006-7024
Open Access | Times Cited: 11
Identificación y caracterización de eventos adversos asociados a la utilización de Cannabis: Revisión estructurada
Valeria Silva-Rivera, Valentina Lopera, Pedro Amariles
Ars Pharmaceutica (Internet) (2025) Vol. 66, Iss. 2, pp. 210-224
Open Access
Clinical Benefits and Safety of Medical Cannabis Products: A Narrative Review on Natural Extracts
Gérard Mick, Pascal Douek
Pain and Therapy (2024) Vol. 13, Iss. 5, pp. 1063-1094
Open Access | Times Cited: 3
Cannabinoids and healthy ageing: the potential for extending healthspan and lifespan in preclinical models with an emphasis on Caenorhabditis elegans
Zhizhen Wang, Jonathon C. Arnold
GeroScience (2024) Vol. 46, Iss. 6, pp. 5643-5661
Closed Access | Times Cited: 2
Online information on medical cannabis is not always aligned with scientific evidence and may raise unrealistic expectations
Arthur C. Macedo, André Oliveira Vilela de Faria, Isabella Harb Bizzi, et al.
Journal of Cannabis Research (2022) Vol. 4, Iss. 1
Open Access | Times Cited: 12
Knowledge, experiences, and attitudes of Australian General Practitioners towards medicinal cannabis: a 2021–2022 survey
Zeeta Bawa, Danielle McCartney, Ramesh Manocha, et al.
BMC Primary Care (2022) Vol. 23, Iss. 1
Open Access | Times Cited: 12
Cannabis and Cannabinoids in Multiple Sclerosis: From Experimental Models to Clinical Practice—A Review
Carmen Adella Sîrbu, Ruxandra Georgescu, Florentina Cristina Pleşa, et al.
American Journal of Therapeutics (2022) Vol. 30, Iss. 3, pp. e220-e231
Closed Access | Times Cited: 9
A Retrospective Medical Record Review of Adults with Non-Cancer Diagnoses Prescribed Medicinal Cannabis
Michael J. Morris, Richard Chye, Zhixin Liu, et al.
Journal of Clinical Medicine (2023) Vol. 12, Iss. 4, pp. 1483-1483
Open Access | Times Cited: 5
What is the hype on #MedicinalCannabis in the United States? A content analysis of medicinal cannabis tweets
Carmen Lim, Tianze Sun, Coral Gartner, et al.
Drug and Alcohol Review (2023) Vol. 43, Iss. 1, pp. 28-35
Open Access | Times Cited: 5
Medicinal Cannabis and Implications for Workplace Health and Safety: Scoping Review of Systematic Reviews
Veronica O’Neill, Nektarios Karanikas, Adem Sav, et al.
Workplace Health & Safety (2023) Vol. 71, Iss. 9, pp. 400-410
Open Access | Times Cited: 4
Update on cannabis in human sexuality
Denis Lissitsa, May Hovers, Michal Shamuilova, et al.
Psychopharmacology (2024) Vol. 241, Iss. 9, pp. 1721-1730
Open Access | Times Cited: 1
The addition of cannabis to prescription drug monitoring programs and medication fills in Medicaid
Shelby R. Steuart
Health Economics (2024) Vol. 34, Iss. 2, pp. 283-296
Closed Access | Times Cited: 1
Using Cannabis and CBD to Sleep: An Updated Review
Isobel Lavender, Gill Garden, Ronald R. Grunstein, et al.
Current Psychiatry Reports (2024)
Closed Access | Times Cited: 1
Medicinal Cannabis and the Intestinal Microbiome
Luis Vitetta, Tamara Nation, Debbie Oldfield, et al.
Pharmaceuticals (2024) Vol. 17, Iss. 12, pp. 1702-1702
Open Access | Times Cited: 1
Medicinal cannabis for Australian patients with chronic refractory pain including arthritis
Elise A. Schubert, Masego T Johnstone, Melissa J. Benson, et al.
British Journal of Pain (2022) Vol. 17, Iss. 2, pp. 206-217
Closed Access | Times Cited: 6
Medicinal cannabis for patients with chronic non-cancer pain: analysis of safety and concomitant medications
Elise A. Schubert, Jan‐Willem C. Alffenaar, Masego T Johnstone, et al.
International Journal of Pharmacy Practice (2022) Vol. 31, Iss. 1, pp. 70-79
Open Access | Times Cited: 5
Challenges and considerations for treating PTSD with medicinal cannabis: the Australian clinician’s perspective
Luke J. Ney, Wọlé Akóṣílè, Christopher G. Davey, et al.
Expert Review of Clinical Pharmacology (2023) Vol. 16, Iss. 11, pp. 1093-1108
Open Access | Times Cited: 2
The potential for medicinal cannabis to help manage challenging behaviour in people with intellectual disability: A perspective review
Laura Korb, Samuel Tromans, Bhathika Perera, et al.
Journal of Psychopharmacology (2023) Vol. 37, Iss. 12, pp. 1201-1208
Open Access | Times Cited: 2
Automated Detection of Cannabis-Induced Alteration in Cardiac Autonomic Regulation of the Indian Paddy-Field Workers Using Empirical Mode Decomposition, Discrete Wavelet Transform and Wavelet Packet Decomposition Techniques with HRV Signals
Suraj Kumar Nayak, Maciej Jarzębski, Anna Gramza‐Michałowska, et al.
Applied Sciences (2022) Vol. 12, Iss. 20, pp. 10371-10371
Open Access | Times Cited: 4
Medicinal cannabis in neurodegenerative disorders: an open label, dose finding, safety and efficacy study
Peter K. Panegyres, Kerry L Lind, Cheryl A MacFarlane, et al.
Neurodegenerative Disease Management (2024) Vol. 14, Iss. 2, pp. 35-46
Closed Access
Page 1 - Next Page

Scroll to top